Geron Corporation announced the appointment of Michelle J. Robertson as Executive Vice President and Treasurer, effective September 25, 2023, succeeding Olivia K. Bloom, who will retire from that role with the Company on that date. In her role as Executive Vice President, Chief Financial Officer and Treasurer, Ms. Robertson will succeed Ms. Bloom as the Company?s principal financial and accounting officer. Ms. Robertson, 56, most recently served as the Chief Financial Officer and Treasurer of Editas Medicine Inc., a CRISPR genome editing company, from January 2020 to May 2023.

Before that, she served as Chief Financial Officer of Momenta Pharmaceuticals Inc. from 2018 until 2020, when Momenta was acquired by Johnson & Johnson. Prior to joining Momenta, Ms. Robertson held multiple commercial finance roles of increasing responsibility, including Vice President, Oncology Finance for Baxalta Incorporated following its spin-off from Baxter International Inc., from 2015 to 2016; Head of Financial Planning and Analysis and Operations Excellence at Ironwood Pharmaceuticals Inc. from 2012 to 2015; and various finance and commercial operations roles at Genzyme Corporation (acquired by Sanofi). Ms. Robertson received her B.S. in Finance and A.S. in Accounting and Management from Bentley University.

She also currently serves as a member of the board of directors and as the chair of the audit committee for Verastem Inc., a publicly-traded biopharmaceutical company.